Over 30% of Covaxin takers experienced nervous system disorders, menstrual abnormalities, suggests study

While a study conducted by researchers at Banaras Hindu University (BHU) found that nearly one-third of those who received Bharat Biotech's Covid-19 vaccine Covaxin reported Adverse Events of Special Interest (AESI) after a one-year follow-up, the Hyderabad-based company cited research flaws. Watch to know more.

India: BHU study raises questions over Covaxin jab, says '1 in 3 reported adverse effects'

Centre approves Russian vaccine ‘Sputnik’ booster COVID-19 shot: Report

India gives emergency use authorisation to Covaxin for 6-12 age group

Covaxin booster offers long-term protection against severe Covid infection: Bharat Biotech

The Drug Controller General of India (DCGI) on Saturday approved Covaxin for emergency use for children above 12 years. The approval is for children between 12 to 18 years of age only. The vaccine is not for children below 12 years.

Drug Controller General of India approves Covaxin for emergency use for children above 12 yrs

Omicron threat: Covaxin maker Bharat Biotech studying if vaccine works against variant

Covaxin 50 per cent effective against virus, says Lancet study

A 'positive' decision: New Zealand includes Covishield, Covaxin in list of recognised vaccines

India-made Covid vaccine Covaxin is 77.8% effective, says data published in Lancet journal

There are concerns about use of the vaccine in children as young as two. India's Covaxin is under trail for children.

Covaxin under trail for Children

Booster dose to be taken 6 months after Covaxin's 2nd dose: Bharat Biotech CMD

India's Covaxin to be added to UK approved list from November 22

Approval sought in US for India-made Covaxin's use on those aged 2 to 18

According to reports, India's Covaxin vaccine has been approved by the WHO for emergency use. The 'made-in-India' vaccine will now be recognized by other nations and Indians who received the jab need not self-quarantine or face covid-19 restrictions. WION's principal diplomatic correspondent Siddhant Sibbal brings all the latest information.

India's Covaxin approved by WHO for emergency use

Indian travellers now allowed to enter US after Covaxin gets nod by WHO

Covaxin gets WHO's nod; here's what it will mean for those who have taken the shot

India's indigenous jab Covaxin approved for emergency use listing by WHO

Bharat Biotech's Covid vaccine Covaxin gets emergency use listing from WHO panel

According to reports, India's Covaxin vaccine has been approved by the WHO for emergency use. The 'made-in-India' vaccine will now be recognized by other nations and Indians who received the jab need not self-quarantine or face covid-19 restrictions.

Covid Vaccine Updates: India's indigenous vaccine Covaxin approved for Emergency use by WHO

Australia now formally recognises two made in India vaccines Covaxin and Covishield

As WHO delays approval for Covaxin jab, every minute is an eternity for this Indian family

Meet, demand more data & reschedule. This has been the WHO's strategy on approving India's homegrown jab - Covaxin. Are WHO experts delaying the approval on purpose? Were all jabs subjected to the same regime? Palki Sharma tells you.

Gravitas: Is WHO delaying approval for COVAXIN?

Delayed again: WHO seeks more 'clarifications' on made-in-India Covid shot Covaxin

covaxin

Covaxin, News on Covaxin, stories on Covaxin, articles on Covaxin, Covaxin stories at Wion, Covaxin news, Covaxin latest news